Preclarus vs ADAURA2 China

Use your existing Preclarus Investigator Site Portal account to manage your clinical trials on your mobile device. The Preclarus mobile application provides the following functionality: • Test results review including graphing and trending • Alert review and query resolution • Subject registration • Online specimen accessioning using Generated and Foreign Barcodes • Shipment/specimen tracking • Supply ordering and inventory management • Full integration of data with the web-based version in real time

You are invited to participate in the Astra Zeneca ADAURA2 study. This app is specifically intended for study participants in the ADAURA2 study only. The Masimo MightySat Rx Pulse (model 9909 or 9907) Oximeter is a Class B digital device, pursuant to part 15 of the FCC Rules and has been been tested and found to comply with the Class B limits for medical devices according to the EN 60601-1-2: 2007, Medical Device Directive 93/42/EEC. The device has Declaration of Comformity (CE) for the following countries: Argentina, Brazil, Canada, Germany, Italy, Japan, Malaysia, Poland, Romania, Singapore, South Korea, Spain, Taiwan, Thailand, Turkey, United Kingdom, and the United States Disclaimer: Use of this app, sensor, and platform is in the context of a clinical study under the supervision of a physician. Patients should seek advice from their healthcare provider as needed and before making any medical decisions.